On 2025-05-01, X4 Pharmaceuticals, Inc. (XFOR) announced earnings per share of $0.04 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-4.13.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-4.17 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-01 | 2025-03-31 | $-4.13 | $0.04 |
| 2025-03-25 | 2024-12-31 | $-5.11 | $-6.01 |
| 2024-11-13 | 2024-09-30 | $-5.11 | $-5.41 |
| 2024-08-08 | 2024-06-30 | $-1.50 | $-2.10 |
| 2024-05-07 | 2024-03-31 | $-5.11 | $-7.81 |
| 2024-03-21 | 2023-12-31 | $-4.50 | $-3.00 |
| 2023-11-09 | 2023-09-30 | $-4.50 | $-0.30 |
| 2023-08-10 | 2023-06-30 | $-5.11 | $-9.91 |
| 2023-05-04 | 2023-03-31 | $-6.01 | $-4.80 |
| 2023-03-21 | 2022-12-31 | $-6.91 | $-8.71 |
| 2022-11-03 | 2022-09-30 | $-9.31 | $-7.81 |
| 2022-08-04 | 2022-06-30 | $-19.52 | $-18.02 |
| 2022-05-12 | 2022-03-31 | $-18.62 | $-21.62 |
| 2022-03-17 | 2021-12-31 | $-20.42 | $-37.24 |
| 2021-11-04 | 2021-09-30 | $-21.62 | $-22.82 |
| 2021-08-03 | 2021-06-30 | $-21.92 | $-22.22 |
| 2021-05-06 | 2021-03-31 | $-25.23 | $-39.04 |
| 2021-03-04 | 2020-12-31 | $-26.13 | $-27.33 |
| 2020-11-05 | 2020-09-30 | $-22.22 | $-26.13 |
| 2020-07-30 | 2020-06-30 | $-21.02 | $-22.82 |
| 2020-05-07 | 2020-03-31 | $-24.92 | $-16.82 |
| 2020-03-12 | 2019-12-31 | $-22.82 | $-19.82 |
| 2019-11-07 | 2019-09-30 | $-28.53 | $-28.53 |
| 2019-08-06 | 2019-06-30 | $-25.23 | $-30.63 |
| 2019-05-15 | 2019-03-31 | -- | $-200.30 |
| 2018-11-09 | 2018-09-30 | $-88.27 | $-136.91 |
| 2018-08-13 | 2018-06-30 | $-144.12 | $-153.12 |
| 2018-05-10 | 2018-03-31 | $-223.38 | $-133.31 |
| 2018-03-09 | 2017-12-31 | $-549.44 | $-302.64 |